The Lipid Manufacturing Market CAGR to Exceed 11.8% by 2035, Due to Growing Demand of LNPs as Drug Delivery System| Roots Analysis

According to the recently published report by Roots Analysis, the growing demand for nanoparticle drug delivery systems with higher solubility is driving the lipid manufacturing market.

Lipid Manufacturing Market Overview

The global lipid nanoparticle manufacturing market is estimated to be worth USD 0.66 billion in 2023 and is expected to grow at a compounded annual growth rate (CAGR) of 11.8% during the forecast period 2023-2035.

The pharmaceutical industry has witnessed substantial growth within the past few decades due to the rising demand for therapeutic drugs. Despite increasing demand, close to 40% of the therapeutic products in development pipelines possess poor water solubility, bioavailability, and permeability. The low solubility reduces the effectiveness of the therapeutic drugs inside the body. To overcome these challenges, pharmaceutical companies search for drug-delivery molecules that facilitate drug delivery into the body.

Pharmaceuticals companies are following numerous approaches to enhance the bioavailability and solubility of the therapeutic agents. Amongst various approaches, lipid nanoparticles and lipidic excipients have gained attention of the drug developers.

Lipid nanoparticles serve as a drug delivery agent, encapsulating the drugs and delivering them to the targeted sites. Lipids are made with small-size ionizable liposomes and have multifunctional behavior because they are used to deliver several drugs and mRNA-based vaccines at targeted sites. Owing to the surface functionalization and inherent properties of the lipids, the lipid manufacturing market is likely to grow in the foreseen future.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:

https://www.rootsanalysis.com/reports/lipid-nanoparticle-manufacturing-market.html

Market Drivers

Several factors that are propelling the lipid manufacturing market growth include increasing demand for lipids as drug delivery systems for cell and gene therapies. Over the past few years, the increase in the demand for advanced drug solutions for the treatment of diseases has also accelerated the demand for lipids in the market. Solid lipid nanoparticles have been extensively used as a drug delivery agent in mRNA-based vaccines. Owing to its increasing demand in the pharmaceutical industry as well as other industrial sectors, it is anticipated that the lipid manufacturing market will witness a significant rise in the market during the forecast period 2023-2035.

Market Restraints

Despite the substantial growth of the lipid manufacturing market, companies face enormous challenges. The primary challenge is the huge cost associated with the development process of lipid-based therapeutics drugs. The raw material for lipid manufacturing has to be sourced, which is time consuming and increases the cost of lipid molecules production. Additionally, lipid manufacturers also face operational challenges as they require precise control and size distribution and also possess sterilization problems. The companies also have to follow regulatory requirements such as cGMP regulations to get approval from the FDA.

Growth Factors

Despite the challenges faced by the lipid manufacturing market, several growth factors contributed to driving the market forward. One of the significant factors is the expanding pharmaceutical industry, high-end research and development, and health technological advancements. Driven by the increasing demand for diverse lipid molecule ranges and sustainable solutions for drug delivery with higher solubility, lipid manufacturers continue to develop lipid molecules. Additionally, the rising use of lipids as excipients in pharmaceuticals delivers the long shelf life and efficacy of the formulation. As a result, the lipid manufacturing market has garnered significant growth during the forecast period.

Lipid Manufacturing Market Segments

Based On the Type of Lipid Nanoparticles, the Market Is Segmented Into Solid Lipid Nanoparticles and Nanostructured Lipid Centers

• Solid nanoparticles lead the lipid manufacturing market as it is an essential drug delivery system for mRNA-based vaccines and likely to hold the largest share around 97% during forecast period 0f 2023-2035.
• Nanostructured lipid centers are anticipated to show the maximum potential to grow the lipid manufacturing market during the forecast period 2023-2035 at a highest rate of 19% of 2023-2035..

Based on the Type of Molecules Delivered, the Lipid Manufacturing Market is Segmented into Nucleic Acid, Small Molecules and Peptides/Proteins

• Nucleic acid is likely to grow due to the rising demand for drug delivery systems during the forecast period and anticipated to expand at a highest CAGR rate of 45% during 2035.
• Small molecules segment will grow at a CAGR of 41% during the projected period of 2023-2035.

Based on the Company Size, the Lipid Manufacturing Market is Segmented into Small, Mid-Size and Large Companies

• Large and very large size companies hold the highest growth rate of 58% during the projected period of 2023-2035.
• Mid-size companies are likely to witness growth during the forecast period and grow at the highest rate of 19% by 2035.

Based on the Targeted Therapeutic Area, the Lipid Manufacturing Market is segmented into Blood Disorders, Infectious Disease, Oncological Disorder, and Rare Disorders.

• Therapeutic areas such as infectious disease are anticipated to lead the market during the forecast period holding the highest growing rate of 61% during forecast period 2035.
• The Oncological disorder segment is likely to expand by 23% during the projected period holding a major share in the market.

Based on the Type of End-Users, the Lipid Manufacturing Market is Segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutes

• Pharmaceutical companies and biotechnology companies hold the major share around 95% and shape the lipid manufacturing market during the forecast period.
• Academic and research institutes are likely to contribute towards the growth of the lipid manufacturing market and expand at a growth rate of 2.1% during 2035.

Based on the Geographical Region, the Lipid Manufacturing Market is segmented into North America, Europe, and Asia-Pacific.

• North America and Europe has dominated the lipid manufacturing market and accounts for the largest share of 80% during the forecast period 2023-2035.
• Asia Pacific is likely to contribute towards the growth of the lipid manufacturing market in the future and is expected to grow at a CAGR of 19.2% by 2035.

Key Companies Profiled

The lipid manufacturing market report also includes detailed profiles of the key players listed below that offer lipid nanoparticles:

• Acuitas Therapeutics
• Ascendia Pharmaceuticals
• Avanti Polar Lipids
• BIOVECTRA
• CordenPharma
• Creative Biolabs
• Curapath
• Curia
• Emergent Biosolutions
• EUROAPI
• Evonik
• Formumax Scientific
• Fresenius Kabi
• Fujifilm
• Integrated Nanotherapeutics
• Leon-nano drugs
• Matinas BioPharma
• Merck
• Pantherna Therapeutics
• Precision NanoSystems
• TLC Biosciences

You Can Download Free Sample PDF Copy Of This Report At:

https://www.rootsanalysis.com/reports/lipid-nanoparticle-manufacturing-market/request-sample.html

Don’t miss out on other interesting titles: 

1. Sustainable, Biodegradable and Eco-Friendly Packaging Providers Market, 2021-2035
2. Pharmaceutical Contract Manufacturing Market (3rd Edition), 2021-2030
3. Biopharmaceutical Contract Manufacturing Market (4th Edition), 2021-2030
4. Lipid Contract Manufacturing (CMO) Market, 2021-2030

About Roots Analysis

Roots Analysis is a global leader in the pharma/biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists, and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research/consulting services dedicated to serving our clients in the best possible way.

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com